Cargando…
Participant and GP perspectives and experiences of screening for undiagnosed type 2 diabetes in community pharmacy during the Pharmacy Diabetes Screening Trial
BACKGROUND: The Pharmacy Diabetes Screening Trial (PDST) evaluated three approaches to screening for undiagnosed type 2 diabetes mellitus (T2DM) in community pharmacy: (1) paper-based risk assessment (AUSDRISK) alone; and AUSDRISK followed by a point of care test if AUSDRISK ≥ 12; with either (2) Hb...
Autores principales: | Krass, Ines, Twigg, Michael J., Mitchell, Bernadette, Wilson, Frances, Mohebbi, Mohammadreza, Trinder, Peta, Shih, Sophy T. F., Carter, Rob, Versace, Vincent L., McNamara, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693079/ https://www.ncbi.nlm.nih.gov/pubmed/38041094 http://dx.doi.org/10.1186/s12913-023-10269-1 |
Ejemplares similares
-
Pharmacy Diabetes Screening Trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacy
por: Krass, Ines, et al.
Publicado: (2017) -
Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study
por: Alzubaidi, Hamzah Tareq, et al.
Publicado: (2019) -
Factors influencing pharmacy students’ attitudes towards pharmacy practice research and strategies for promoting research interest in pharmacy practice
por: Kritikos, Vicky S., et al.
Publicado: (2015) -
Cost-effectiveness and cost-utility analysis of type-2 diabetes screening in pharmacies in Iran
por: Amirsadri, Mohammadreza, et al.
Publicado: (2023) -
A Comparison of Screening Methods for Sleep Disorders in Australian Community Pharmacies: A Randomized Controlled Trial
por: Fuller, Joanne M., et al.
Publicado: (2014)